C. Shi

PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity.

Xindi Ma, Yutong He, Yuan Gao, 2023, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

The expression landscape of FOXP3 and its prognostic value in breast cancer

Xindi Ma, Shuguang Ren, Yunjiang Liu, 2022, Annals of translational medicine.